Annual Updates

HIV/AIDS Annual Update 2009

Modules

• The Virus, the Tissues and Immune Activation: What Makes HIV Infection Pathogenic?
• New Insights Into Persistent Low-Level Viremia
• Timing and Choice of First-Line Antiretroviral Therapy
• Inflammation and Non-AIDS Events: Are Antiretroviral-Treated Patients Aging Too Quickly and If So, Why?
• Update on Managing Methamphetamine Abuse in the Setting of HIV Infection
• State-of-the-Art Management of Sexually Transmitted Diseases
• Biomedical Approaches to Prevention
• Experiences as an HIV Provider in Africa

HIV/AIDS Annual Update 2009 Book

• Download

HIV/AIDS Annual Update 2008

Modules

• HIV Disease Pathogenesis and the Gastrointestinal Tract
• Eradication of HIV: Possible or Still a Pipe Dream?
• New Findings on Resistance to NRTIs, NNRTIs, and PIs
• Novel Antiretroviral Agents
• Clinical Strategies for Initiation of Antiretroviral Therapy
• Non−AIDS-Defining Cancers in the Era of HAART
• Neurologic Aspects of HIV Infection and Its Therapy
• Advances in HIV/HCV Coinfection
• The US HIV Epidemic: Why Is Prevention Failing?
• The Global HIV Epidemic: Update on Epidemiology and Prevention

HIV/AIDS Annual Update 2007

Modules

• Viral and Host Factors Affecting HIV-1 Transmission
• Mechanisms of Immune Deficiency in HIV Infection
• Timing and Choice of Therapy in Treatment-Naive Patients
• New Drugs for Treatment-Experienced Patients
• Inhibitors of Human Immunodeficiency Virus Type I Integration
• Update on HIV/HBV Coinfection
• Management of Pregnancy in HIV-Infected Women
• Aging and the HIV-Infected Patient
• An HIV-1–Specific Microbicide Is a Public Health Priority
• HIV and TB in Sub-Saharan Africa: Learning From a Catastrophic Collision

HIV/AIDS Annual Update 2006

Modules

• Immune Control and Immune Failure in HIV Infection
• Viral Pathogenesis: HIV Persistence and Resistance in Latent Reservoirs
• Progress of Entry Inhibitors: Where Are We Now and Where Are We Going?
• New Drugs for Treatment-Experienced Patients
• Clinical Strategies for Initiation of Antiretroviral Therapy
• Management of Pediatric/Adolescent HIV and Transition to Adulthood
• Management and Emerging Issues in Sexually Transmitted Diseases
• Management Update on Hepatitis/HIV Coinfection
• Managing Methamphetamine Abuse in the Setting of HIV Infection
• Technological Advances in HIV Prevention

CCO Slidesets

• HIV/AIDS Annual Update 2006 Part 1
• HIV/AIDS Annual Update 2006 Part 2

HIV/AIDS Annual Update 2005

Modules

• The Role of Immune Activation in the Pathogenesis of HIV Infection
• Blocking HIV Attachment and Entry
• Novel Antiretroviral Agents
• HIV Resistance: Improving Interpretation and Recent Insights
• Clinical Strategies for Treatment-Experienced Patients
• Clinical Relevance of Advances in Pharmacogenomics
• Strategies for Managing Hyperlipidemia in HIV Disease
• Update on the Management of HIV-Infected Women
• New Insights Into Prevention of HIV and Other Sexually Transmitted Infections
• 10 Ways to Solve AIDS in Africa

HIV/AIDS Annual Update 2004

Modules

• Positive and Negative Factors Influencing HIV-Host Cell Interplay
• Immunopathogenesis: Innate Immunity
• Treatment of Antiretroviral-Naive Patients
• New Insights Into HIV-1 Drug Resistance
• Managing Cardiovascular Risk in Patients With HIV Infection
• HIV Treatment in Challenging Populations
• Pharmacology Update: Drug-Drug Interactions and Ethnic and Sex Differences
• Update on AIDS-Related Malignancies
• Treatment of Viral Hepatitis Coinfection
• Solid Organ Transplantation in HIV-Infected Recipients in the HAART Era

HIV/AIDS Annual Update 2003

Modules

• Immune Control and Immune Failure in HIV Infection
• Viral Pathogenesis: Clinical Implications of HIV-1 Latent Reservoirs
• Treatment of Antiretroviral-Naive Patients
• HIV-1 Drug Resistance: from Mechanisms to Management
• Novel Antiretroviral Agents
• Management of Hepatitis Virus Coinfection in HIV-Infected Patients
• HIV-Associated Lipodystrophy: Mechanisms and Management
• HIV Infection in Women: An Update

Animations

• The Role of Integrase in HIV Replication

HIV/AIDS Annual Update 2002

Modules

• Viral Pathogenesis: HIV Attachment and Entry
• Immunopathogenesis and Immune Reconstitution
• Treatment Strategies for Antiretroviral-Experienced Patients
• Entry Inhibitors
• Resistance: From Bench to Bedside
• Pathogenesis & Epidemiology of Metabolic Abnormalities
• Screening And Prevention For Cardiovascular Complications In The HAART Era
• Mitochondrial Toxicity
• Management of Morphologic Changes During Antiretroviral Therapy: Insights From Etiology
• AIDS-Related Malignancies in the Era of HAART
• Screening for and Treatment of Anal Intraepithelial Neoplasia

Animations

• Fusion and Cell Entry
• Fusion Inhibition
• Phase 3 Studies of T-20 in Salvage Theory